LiVeritas Biosciences improves human health by helping get new therapeutics to patients safer and faster. We are a digital-focused analytical testing company dedicated to empowering our clients to meet accelerated drug development timelines via rapid and strategic implementation of transformative new technologies. Founded in 2020 for Industry 4.0, LiVeritas uses state-of-the-art instrumentation and a broad suite of proprietary AI-powered analytical solutions to address our client’s mass spectrometry and other data needs. LiVeritas created the LiLii™ platform integrating high-quality data for pre-clinical and clinical testing to streamline our client’s development of new therapeutics targeting human diseases.
For conference production and speaking opportunites:
Für die Produktion von Konferenzen und die Möglichkeit, Vorträge zu halten: